{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:02:26Z","timestamp":1791133346070,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T00:00:00Z","timestamp":1358812800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2012.149","type":"journal-article","created":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T14:41:58Z","timestamp":1358865718000},"page":"e221-e221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia"],"prefix":"10.1038","volume":"3","author":[{"given":"L","family":"Urig\u00fcen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Gil-Pisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Munarriz-Cuezva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Berrocoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Pascau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Soto-Montenegro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Guti\u00e9rrez-Ad\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Pintado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L M","family":"Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"S\u00e1nchez-Bl\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J E","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ferrer-Alcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Garc\u00eda-Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Mic\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Desco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Leza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1","family":"Pazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Garz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J","family":"Meana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,22]]},"reference":[{"key":"BFtp2012149_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","volume":"374","author":"J van Os","year":"2009","unstructured":"van Os J, Kapur S . Schizophrenia. Lancet 2009; 374: 635\u2013645.","journal-title":"Lancet"},{"key":"BFtp2012149_CR2","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes OD, Kapur S . The dopamine hypothesis of schizophrenia: version III\u2013the final common pathway. Schizophr Bull 2009; 35: 549\u2013562.","journal-title":"Schizophr Bull"},{"key":"BFtp2012149_CR3","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1176\/appi.ajp.162.12.2233","volume":"162","author":"R Honea","year":"2005","unstructured":"Honea R, Crow TJ, Passingham D, Mackay CE . Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 2005; 162: 2233\u20132245.","journal-title":"Am J Psychiatry"},{"key":"BFtp2012149_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1001\/archgenpsychiatry.2011.150","volume":"69","author":"C Arango","year":"2012","unstructured":"Arango C, Rapado-Castro M, Reig S, Castro-Fornieles J, Gonzalez-Pinto A, Otero S et al. Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry 2012; 69: 16\u201326.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp2012149_CR5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.18388\/abp.2008_3022","volume":"55","author":"RD Johnson","year":"2008","unstructured":"Johnson RD, Oliver PL, Davies KE . SNARE proteins and schizophrenia: linking synaptic and neurodevelopmental hypotheses. Acta Biochim Pol 2008; 55: 619\u2013628.","journal-title":"Acta Biochim Pol"},{"key":"BFtp2012149_CR6","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1126\/science.1161748","volume":"323","author":"TC Sudhof","year":"2009","unstructured":"Sudhof TC, Rothman JE . Membrane fusion: grappling with SNARE and SM proteins. Science 2009; 323: 474\u2013477.","journal-title":"Science"},{"key":"BFtp2012149_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1749-6632.2008.03987.x","volume":"1152","author":"RD Burgoyne","year":"2009","unstructured":"Burgoyne RD, Barclay JW, Ciufo LF, Graham ME, Handley MT, Morgan A . The functions of Munc18-1 in regulated exocytosis. Ann NY Acad Sci 2009; 1152: 76\u201386.","journal-title":"Ann NY Acad Sci"},{"key":"BFtp2012149_CR8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.tins.2007.08.008","volume":"30","author":"RF Toonen","year":"2007","unstructured":"Toonen RF, Verhage M . Munc18-1 in secretion: lonely Munc joins SNARE team and takes control. Trends Neurosci 2007; 30: 564\u2013572.","journal-title":"Trends Neurosci"},{"key":"BFtp2012149_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.biopsych.2009.07.029","volume":"67","author":"MA Castillo","year":"2010","unstructured":"Castillo MA, Ghose S, Tamminga CA, Ulery-Reynolds PG . Deficits in syntaxin 1 phosphorylation in schizophrenia prefrontal cortex. Biol Psychiatry 2010; 67: 208\u2013216.","journal-title":"Biol Psychiatry"},{"key":"BFtp2012149_CR10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/mp.2008.7","volume":"14","author":"AT Behan","year":"2009","unstructured":"Behan AT, Byrne C, Dunn MJ, Cagney G, Cotter DR . Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. Mol Psychiatry 2009; 14: 601\u2013613.","journal-title":"Mol Psychiatry"},{"key":"BFtp2012149_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1017\/S1461145711000861","volume":"14","author":"I Gil-Pisa","year":"2012","unstructured":"Gil-Pisa I, Munarriz-Cuezva E, Ramos-Miguel A, Uriguen L, Meana JJ, Garcia-Sevilla JA . Regulation of munc18-1 and syntaxin-1A interactive partners in schizophrenia prefrontal cortex: down-regulation of munc18-1a isoform and 75 kDa SNARE complex after antipsychotic treatment. Int J Neuropsychopharmacol 2012; 14: 573\u2013588.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFtp2012149_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1083\/jcb.129.1.105","volume":"129","author":"EP Garcia","year":"1995","unstructured":"Garcia EP, McPherson PS, Chilcote TJ, Takei K, De Camilli P . rbSec1A and B colocalize with syntaxin 1 and SNAP-25 throughout the axon, but are not in a stable complex with syntaxin. J Cell Biol 1995; 129: 105\u2013120.","journal-title":"J Cell Biol"},{"key":"BFtp2012149_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1006\/geno.1997.5202","volume":"48","author":"DA Swanson","year":"1998","unstructured":"Swanson DA, Steel JM, Valle D . Identification and characterization of the human ortholog of rat STXBP1, a protein implicated in vesicle trafficking and neurotransmitter release. Genomics 1998; 48: 373\u2013376.","journal-title":"Genomics"},{"key":"BFtp2012149_CR14","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/nn.2647","volume":"13","author":"EJ Nestler","year":"2010","unstructured":"Nestler EJ, Hyman SE . Animal models of neuropsychiatric disorders. Nat Neurosci 2010; 13: 1161\u20131169.","journal-title":"Nat Neurosci"},{"key":"BFtp2012149_CR15","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.biopsych.2006.05.008","volume":"59","author":"CM Powell","year":"2006","unstructured":"Powell CM, Miyakawa T . Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? Biol Psychiatry 2006; 59: 1198\u20131207.","journal-title":"Biol Psychiatry"},{"key":"BFtp2012149_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/A:1008926022370","volume":"9","author":"A Gutierrez-Adan","year":"2000","unstructured":"Gutierrez-Adan A, Pintado B . Effect of flanking matrix attachment regions on the expression of microinjected transgenes during preimplantation development of mouse embryos. Transgenic Res 2000; 9: 81\u201389.","journal-title":"Transgenic Res"},{"key":"BFtp2012149_CR17","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.euroneuro.2010.04.008","volume":"20","author":"JA Garcia-Sevilla","year":"2010","unstructured":"Garcia-Sevilla JA, Alvaro-Bartolome M, Diez-Alarcia R, Ramos-Miguel A, Puigdemont D, Perez V et al. Reduced platelet G protein-coupled receptor kinase 2 in major depressive disorder: antidepressant treatment-induced upregulation of GRK2 protein discriminates between responder and non-responder patients. Eur Neuropsychopharmacol 2010; 20: 721\u2013730.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtp2012149_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0028-3908(00)00094-0","volume":"40","author":"VA Vaidya","year":"2001","unstructured":"Vaidya VA, Castro ME, Pei Q, Sprakes ME, Grahame-Smith DG . Influence of thyroid hormone on 5-HT(1A) and 5-HT(2A) receptor-mediated regulation of hippocampal BDNF mRNA expression. Neuropharmacology 2001; 40: 48\u201356.","journal-title":"Neuropharmacology"},{"key":"BFtp2012149_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00213-009-1608-2","volume":"206","author":"L Urig\u00fcen","year":"2009","unstructured":"Urig\u00fcen L, Garcia-Fuster MJ, Callado LF, Morentin B, La Harpe R, Casado V et al. Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment. Psychopharmacology 2009; 206: 313\u2013324.","journal-title":"Psychopharmacology"},{"key":"BFtp2012149_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nature06612","volume":"452","author":"J Gonzalez-Maeso","year":"2008","unstructured":"Gonzalez-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, Lopez-Gimenez JF et al. Identification of a serotonin\/glutamate receptor complex implicated in psychosis. Nature 2008; 452: 93\u201397.","journal-title":"Nature"},{"key":"BFtp2012149_CR21","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.neuropharm.2004.01.003","volume":"46","author":"L Uriguen","year":"2004","unstructured":"Uriguen L, Perez-Rial S, Ledent C, Palomo T, Manzanares J . Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 2004; 46: 966\u2013973.","journal-title":"Neuropharmacology"},{"key":"BFtp2012149_CR22","volume-title":"The Mouse Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"2001","unstructured":"Paxinos G, Franklin KBJ . The Mouse Brain in Stereotaxic Coordinates. Academic Press: San Diego, 2001."},{"key":"BFtp2012149_CR23","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.euroneuro.2010.07.008","volume":"20","author":"JE Ortega","year":"2010","unstructured":"Ortega JE, Fernandez-Pastor B, Callado LF, Meana JJ . In vivo potentiation of reboxetine and citalopram effect on extracellular noradrenaline in rat brain by alpha(2)-adrenoceptor antagonism. Eur Neuropsychopharmacol 2010; 20: 813\u2013822.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtp2012149_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nbd.2008.09.016","volume":"33","author":"SJ Sawiak","year":"2009","unstructured":"Sawiak SJ, Wood NI, Williams GB, Morton AJ, Carpenter TA . Voxel-based morphometry in the R6\/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry. Neurobiol Dis 2009; 33: 20\u201327.","journal-title":"Neurobiol Dis"},{"key":"BFtp2012149_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/cercor\/8.2.108","volume":"8","author":"F Conti","year":"1998","unstructured":"Conti F, DeBiasi S, Minelli A, Rothstein JD, Melone M . EAAC1, a high-affinity glutamate tranporter, is localized to astrocytes and gabaergic neurons besides pyramidal cells in the rat cerebral cortex. Cereb Cortex 1998; 8: 108\u2013116.","journal-title":"Cereb Cortex"},{"key":"BFtp2012149_CR26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","volume":"16","author":"JD Rothstein","year":"1996","unstructured":"Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996; 16: 675\u2013686.","journal-title":"Neuron"},{"key":"BFtp2012149_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrn898","volume":"3","author":"J Rizo","year":"2002","unstructured":"Rizo J, Sudhof TC . Snares and Munc18 in synaptic vesicle fusion. Nat Rev Neurosci 2002; 3: 641\u2013653.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp2012149_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neuron.2006.09.023","volume":"52","author":"PA Arguello","year":"2006","unstructured":"Arguello PA, Gogos JA . Modeling madness in mice: one piece at a time. Neuron 2006; 52: 179\u2013196.","journal-title":"Neuron"},{"key":"BFtp2012149_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/schbul\/sbp125","volume":"36","author":"CM O'Tuathaigh","year":"2010","unstructured":"O'Tuathaigh CM, Kirby BP, Moran PM, Waddington JL . Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia. Schizophr Bull 2010; 36: 271\u2013288.","journal-title":"Schizophr Bull"},{"key":"BFtp2012149_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","volume":"53","author":"J Gonzalez-Maeso","year":"2007","unstructured":"Gonzalez-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R et al. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 2007; 53: 439\u2013452.","journal-title":"Neuron"},{"key":"BFtp2012149_CR31","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1176\/ajp.156.9.1358","volume":"156","author":"A Aleman","year":"1999","unstructured":"Aleman A, Hijman R, de Haan EH, Kahn RS . Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry 1999; 156: 1358\u20131366.","journal-title":"Am J Psychiatry"},{"key":"BFtp2012149_CR32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s002130100810","volume":"156","author":"DL Braff","year":"2001","unstructured":"Braff DL, Geyer MA, Swerdlow NR . Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 2001; 156: 234\u2013258.","journal-title":"Psychopharmacology"},{"key":"BFtp2012149_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00213-004-1793-y","volume":"174","author":"PS Goldman-Rakic","year":"2004","unstructured":"Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV . Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl) 2004; 174: 3\u201316.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp2012149_CR34","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/385634a0","volume":"385","author":"Y Okubo","year":"1997","unstructured":"Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 1997; 385: 634\u2013636.","journal-title":"Nature"},{"key":"BFtp2012149_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0920-9964(00)00095-5","volume":"52","author":"A Laakso","year":"2001","unstructured":"Laakso A, Bergman J, Haaparanta M, Vilkman H, Solin O, Syvalahti E et al. Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr Res 2001; 52: 115\u2013120.","journal-title":"Schizophr Res"},{"key":"BFtp2012149_CR36","doi-asserted-by":"publisher","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","volume":"93","author":"M Laruelle","year":"1996","unstructured":"Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 1996; 93: 9235\u20139240.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp2012149_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1192\/S0007125000293598","volume":"37","author":"C Tamminga","year":"1999","unstructured":"Tamminga C . Glutamatergic aspects of schizophrenia. Br J Psychiatry Suppl 1999; 37: 12\u201315.","journal-title":"Br J Psychiatry Suppl"},{"key":"BFtp2012149_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.schres.2005.08.014","volume":"81","author":"LA Glantz","year":"2006","unstructured":"Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF . Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res 2006; 81: 47\u201363.","journal-title":"Schizophr Res"},{"key":"BFtp2012149_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.schres.2005.05.019","volume":"78","author":"HG Bernstein","year":"2005","unstructured":"Bernstein HG, Bogerts B, Keilhoff G . The many faces of nitric oxide in schizophrenia. A review. Schizophr Res 2005; 78: 69\u201386.","journal-title":"Schizophr Res"},{"key":"BFtp2012149_CR40","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/schbul\/sbn135","volume":"35","author":"PF Buckley","year":"2009","unstructured":"Buckley PF, Miller BJ, Lehrer DS, Castle DJ . Psychiatric comorbidities and schizophrenia. Schizophr Bull 2009; 35: 383\u2013402.","journal-title":"Schizophr Bull"},{"key":"BFtp2012149_CR41","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.lfs.2010.03.018","volume":"86","author":"J Kosaka","year":"2010","unstructured":"Kosaka J, Takahashi H, Ito H, Takano A, Fujimura Y, Matsumoto R et al. Decreased binding of [11C]NNC112 and [11C]SCH23390 in patients with chronic schizophrenia. Life Sci 2010; 86: 814\u2013818.","journal-title":"Life Sci"},{"key":"BFtp2012149_CR42","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1176\/appi.ajp.159.5.761","volume":"159","author":"P Karlsson","year":"2002","unstructured":"Karlsson P, Farde L, Halldin C, Sedvall G . PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. Am J Psychiatry 2002; 159: 761\u2013767.","journal-title":"Am J Psychiatry"},{"key":"BFtp2012149_CR43","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1523\/JNEUROSCI.22-09-03708.2002","volume":"22","author":"A Abi-Dargham","year":"2002","unstructured":"Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y et al. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 2002; 22: 3708\u20133719.","journal-title":"J Neurosci"},{"key":"BFtp2012149_CR44","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1517\/14728222.10.4.515","volume":"10","author":"P Seeman","year":"2006","unstructured":"Seeman P . Targeting the dopamine D2 receptor in schizophrenia. Expert Opin Ther Targets 2006; 10: 515\u2013531.","journal-title":"Expert Opin Ther Targets"},{"key":"BFtp2012149_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0074-7742(06)78001-1","volume":"78","author":"O Guillin","year":"2007","unstructured":"Guillin O, Abi-Dargham A, Laruelle M . Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 2007; 78: 1\u201339.","journal-title":"Int Rev Neurobiol"},{"key":"BFtp2012149_CR46","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s002130000532","volume":"152","author":"S Silvestri","year":"2000","unstructured":"Silvestri S, Seeman MV, Negrete JC, Houle S, Shammi CM, Remington GJ et al. Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology 2000; 152: 174\u2013180.","journal-title":"Psychopharmacology"},{"key":"BFtp2012149_CR47","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/379606a0","volume":"379","author":"B Giros","year":"1996","unstructured":"Giros B, Jaber M, Jones SR, Wightman RM, Caron MG . Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996; 379: 606\u2013612.","journal-title":"Nature"},{"key":"BFtp2012149_CR48","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0166-4328(03)00187-6","volume":"vol. 148","author":"RM Rodriguiz","year":"2004","unstructured":"Rodriguiz RM, Chu R, Caron MG, Wetsel WC . Aberrant responses in social interaction of dopamine transporter knockout mice. Behav Brain Res 2004; vol. 148: 185\u2013198.","journal-title":"Behav Brain Res"},{"key":"BFtp2012149_CR49","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/FBP.0b013e32830dc110","volume":"19","author":"SB Powell","year":"2008","unstructured":"Powell SB, Young JW, Ong JC, Caron MG, Geyer MA . Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice. Behav Pharmacol 2008; 19: 562\u2013565.","journal-title":"Behav Pharmacol"},{"key":"BFtp2012149_CR50","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1111\/j.1471-4159.1993.tb07468.x","volume":"61","author":"SL Vrana","year":"1993","unstructured":"Vrana SL, Vrana KE, Koves TR, Smith JE, Dworkin SI . Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. J Neurochem 1993; 61: 2262\u20132268.","journal-title":"J Neurochem"},{"key":"BFtp2012149_CR51","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","volume":"69","author":"OD Howes","year":"2012","unstructured":"Howes OD, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry 2012; 69: 776\u2013786.","journal-title":"Arch Gen Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/tp2012149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/tp2012149","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2012149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T21:57:45Z","timestamp":1672955865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2012149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,22]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1]]}},"alternative-id":["BFtp2012149"],"URL":"https:\/\/doi.org\/10.1038\/tp.2012.149","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,22]]},"assertion":[{"value":"22 January 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LU, MJG, MF-A and JJM are authors of a patent (WO\/2010\/020642) related to munc18-1 in schizophrenia owned by Brainco Biopharma SL and UPV\/EHU. JJM and AP have received research funds from Brainco Biopharma SL.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}